For research use only. Not for use in humans.

Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3))

Synonyms: LM 609

Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.

Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3))

Quality Control

Batch: A299101 Purity: 99% Protein concentration: 16.91mg/ml Endotoxin Level: <1EU/mg
99

Specificity

Name Citation Integrin ILK Others
Cilengitide trifluoroacetate 70
A-205804 6
GLPG0187 1
GSK-3008348 HCl 0
Bexotegrast (PLN-74809) 0
Cilengitide 36
OSU-T315 1
TR-14035 0
Cyclo(RGDyK) TFA 14
SB273005 27
RGD (Arg-Gly-Asp) Peptides 26
ILK-IN-3 0
RGD peptide (GRGDNP) 1 caspase-3
ATN-161 22
Cyclo(-RGDfK) TFA 13
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.
References

Product Details

CAS No. 892553-42-3
Molecular Weight 144.18
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.